>I would think that at these levels NBIX would almost certainly be bought by Pfizer.<
Without a sleep maintenance indication, it may not be worth it: see rkrw’s post (#msg-11133915).
I doubt PFE will try to acquire NBIX for their management expertise. (If PFE were interested in bolstering their management team, they would have bid for Eximias )
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”